Investigators described a step-wise, directed-differentiation protocol in which organoids are generated from iPSCs committed to mesenchymal, endothelial, and hematopoietic lineages.
[Cancer Discovery]
Home Newsletters Hematopoiesis News Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic...
